Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Hypoestes Rosea Powder in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypoestes Rosea Powder

Snippet

Sponsor: University of Ibadan | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED